When we hear the word “nicotine,” most of us think about vaping, cigarettes, addiction, and lung cancer. But beneath this stigma lies an interesting paradox: nicotine, the same compound that makes ...

Australian skinks possess a remarkable natural immunity to deadly snake venom, stemming from a genetic mutation in a critical ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fisca ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...

Anti-obesity drugs such as semaglutide (Ozempic, Wegovy) are also promising for the treatment of alcohol use disorder and alcohol-associated liver disease, as growing evidence suggests they reduce the ...

A dataset named CARDIOPEG has been uploaded to the Dryad website. It contains all the individual experiments used for the figures in the article.

VIENNA — Adults with obesity but without diabetes who took the investigational, oral GLP-1 receptor agonist orforglipron for 72 weeks lost significantly more weight than those on placebo, according to ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between them, ultimately destroying the neural networks that underlie our memories ...

In this phase 3, multinational, randomized, double-blind trial, we examined the safety and efficacy of once-daily orforglipron at doses of 6 mg, 12 mg, or 36 mg, as compared with placebo (assigned in ...

Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning 530021, Guangxi, P. R. China School of Chemistry & Materials Science, Jiangsu Normal University, Xuzhou 221116, P. R. China ...